Immunomodulatory Strategies for Celiac Disease

REFERENCES

• H. Arentz-Hansen, S.N. McAdam, O. Molberg, B. Fleckenstein, K.E. Lundin, T.J. Jorgensen, G. Jung, P. Roepstorff, and L.M. Sollid, Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues, Gastroenterology, 123: 803–809, 2002. [CSA]
   PubMed Web of Science ®Google Scholar
• H. Arentz-Hansen, R. Corner, O. Molberg, H. Quarsten, W. Vader, Y.M. Kooy, K.E. Lundin, F. Koning, P. Roepstorff, L.M. Sollid, and S.N. McAdam, The intestinal T- cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase, J. Exp. Med., 191: 603–612, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Sjostrom, K.E. Lundin, O. Molberg, R. Corner, S.N. McAdam, D. Anthonsen, H. Quarsten, O. Noren, P. Roepstorff, E. Thorsby, , et al., Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition, Scand. J. Immunol., 48: 111–115, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. Vader, Y. Kooy, P. Van Veelen, A. De Ru, D. Harris, W. Benckhuijsen, S. Pena, L. Mearin, J.W. Drijfhout, and F. Koning, The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides, Gastroenterology, 122: 1729–1737, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.M. Sollid, Coeliac disease: dissecting a complex inflammatory disorder, Nat. Rev. Immunol., 2: 647–655, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Naik, E.J. Kelly, L. Meijer, S. Pettersson, and I.R. Sanderson, Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium, J. Pediatr. Gastroenterol. Nutr., 32: 449–453, 2001. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M.T. Abreu, P. Vora, E. Faure, L.S. Thomas, E.T. Arnold, and M. Arditi, Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide, J. Immunol., 167: 1609–1616, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• A.M. Mowat, P. Garside, L.A. Fitton, H.R. Higley, and J.A. Carlino, Regulatory activity of endogenous and exogenous transforming growth factor beta in experimental intestinal immunopathology, Growth Factors, 13: 75–85, 1996. [CSA]
   PubMed Web of Science ®Google Scholar
• A. Hamann, D.P. Andrew, D. Jablonski-Westrich, B. Holzmann, and E.C. Butcher, Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo, J. Immunol., 152: 3282–3293, 1994. [CSA]
   PubMed Web of Science ®Google Scholar
• O. Alpan, G. Rudomen, and P. Matzinger, The role of dendritic cells, B cells, and M cells in gut-oriented immune responses, J. Immunol., 166: 4843–4852, 2001. [CSA]
   PubMed Web of Science ®Google Scholar
• T.W. Spahn, A. Fontana, A.M. Faria, A.J. Slavin, H.P. Eugster, X. Zhang, P.A. Koni, N.H. Ruddle, R.A. Flavell, P.D. Rennert, , et al., Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches, Eur. J. Immunol., 31: 1278–1287, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. Friedman and H.L. Weiner, Induction of anergy or active suppression following oral tolerance is determined by antigen dosage, Proc. Natl. Acad. Sci. U. S. A., 91: 6688–6692, 1994. [CSA]
   PubMed Web of Science ®Google Scholar
• C.C. Whitacre, I.E. Gienapp, C.G. Orosz, and D.M. Bitar, Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy, J. Immunol., 147: 2155–2163, 1991. [CSA]
   PubMed Web of Science ®Google Scholar
• D. Melamed and A. Friedman, Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin, Eur. J. Immunol., 23: 935–942, 1993. [CSA]
   PubMed Web of Science ®Google Scholar
• Y. Chen, V.K. Kuchroo, J. Inobe, D.A. Hafler, and H.L. Weiner, Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis, Science, 265: 1237–1240, 1994. [CSA]
   PubMed Web of Science ®Google Scholar
• H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, and M.G. Roncarolo, A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389: 737–742, 1997. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J. Immunol., 155: 1151–1164, 1995. [CSA]
   PubMed Web of Science ®Google Scholar
• B. Salomon, D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Scarpe, and J.A. Bluestone, B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes, Immunity, 12: 431–440, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. Chen and S.M. Wahl, A functional link between CTLA-4 and cell surface-associated TGF-β in CD4+CD25+ suppressor T-cell-mediated immunosuppression, Cytokine Growth Factor Rev., 14: 85–89, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N.M. Tsuji, K. Mizumachi, and J. Kurisaki, Antigen-specific, CD4 + CD25 + regulatory T-cell clones induced in Peyer's patches, Int. Immunol., 15: 525–534, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J. Mengel, F. Cardillo, L.S. Aroeira, O. Williams, M. Russo, and N.M. Vaz, Anti-gamma delta T-cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice, Immunol. Lett., 48: 97–102, 1995. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Y. Ke, K. Pearce, J.P. Lake, H.K. Ziegler, and J.A. Kapp, Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance, J. Immunol., 158: 3610–3618, 1997. [CSA]
   PubMed Web of Science ®Google Scholar
• K. Fujihashi, T. Dohi, M.N. Kweon, J.R. McGhee, T. Koga, M.D. Cooper, S. Tonegawa, and H. Kimono, Gamma delta T cells regulate mucosally induced tolerance in a dose-dependent fashion, Int. Immunol., 11: 1907–1916, 1999. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A.H. Enk, Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells, J. Exp. Med., 192: 1213–1222, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.J. Fairchild and H. Waldmann, Dendritic cells and prospects for transplantation tolerance, Curr. Opin. Immunol., 12: 528–535, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R.M. Steinman, S. Turley, I. Mellman, and K. Inaba, The induction of tolerance by dendritic cells that have captured apoptotic cells, J. Exp. Med., 191: 411–416, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L. Faulkner, G. Buchan, and M. Baird, Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation, Immunology, 99: 523–531, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K. Sato, H. Nagayama, K. Tadokoro, T. Juji, and T.A. Takahashi, Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase and p38MAPK are involved in IL-10-mediated selective repression of TNF-α-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells, J. Immunol., 162: 3865–3872, 1999. [CSA]
   PubMed Web of Science ®Google Scholar
• F. Koch, U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler, High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med., 184: 741–746, 1996. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C. Buelens, V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems, Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol., 27: 1848–1852, 1997. [CSA]
   PubMed Web of Science ®Google Scholar
• P. Brossart, A. Zobywalski, F. Grunebach, L. Behnke, G. Stuhler, V.L. Reichardt, L. Kanz, and W. Brugger, Tumor necrosis factor α and CD40 ligand antagonize the inhibitory effects of interleukin-10 on T-cell stimulatory capacity of dendritic cells, Cancer Res., 60: 4485–4492, 2000. [CSA]
   PubMedGoogle Scholar
• T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbani, O. Leo, and M. Moser, Effect of interleukin-10 on dendritic-cell maturation and function, Eur. J. Immunol., 27: 1229–1235, 1997. [CSA]
   PubMed Web of Science ®Google Scholar
• K. Steinbrink, H. Jonuleit, G. Muller, G. Schuler, J. Knop, and A.H. Enk, Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells, Blood, 93: 1634–1642, 1999. [CSA]
   PubMed Web of Science ®Google Scholar
• D. Vremec, M. Zorbas, R. Scollay, D.J. Saunders, C.F. Ardavin, L. Wu, and K. Shortman, The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med., 176: 47–58, 1992. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Jonuleit, E. Schmitt, K. Steinbrink, and A.H. Enk, Dendritic cells as a tool to induce anergic and regulatory T cells, Trends Immunol., 22: 394–400, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G. Suss and K. Shortman, A subclass of dendritic cells kills CD4+ T cells via Fas-Fas-ligand-induced apoptosis. J. Exp. Med., 183: 1789–1796, 1996. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.D. McLellan and E. Kampgen, Functions of myeloid and lymphoid dendritic cells, Immunol. Lett., 72: 101–105, 2000. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• C. Nagler-Anderson, L.A. Bober, M.E. Robinson, G.W. Siskind, and G.J. Thorbecke, Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen, Proc Natl. Acad. Sci. U. S. A., 83: 7443–7446, 1986. [CSA]
   PubMed Web of Science ®Google Scholar
• H.L. Weiner, A. Friedman, A. Miller, S.J. Khoury, A. al-Sabbagh, L. Santos, M. Sayegh, R.B. Nussenblatt, D.E. Trentham, and D.A. Hafler, Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens, Annu. Rev. Immunol., 12: 809–837, 1994. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S. Lee, N. Scherberg, and L.J. De Groot, Induction of oral tolerance in human autoimmune thyroid disease, Thyroid, 8: 229–234, 1998. [CSA]
   PubMed Web of Science ®Google Scholar
• Z.J. Zhang, L. Davidson, G. Eisenbarth, and H.L. Weiner, Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insuline, Proc. Natl. Acad. Sci. U. S. A., 88: 10252–10256, 1991. [CSA]
   PubMed Web of Science ®Google Scholar
• R.B. Nussenblat, I. Gery, H.L. Weiner, F.L. Ferris, J. Shiloach, N. Remaley, C. Perry, R.R. Caspi, D.A. Hafler, C.S. Foster, and S.M. Whitcup, Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial, Am. J. Opthalmol., 123: 583–592, 1997. [CSA]
   PubMedGoogle Scholar
• H. L. Weiner, Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today, 18: 335–343, 1997. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• S. Brocce, K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, T. Veromaa, A. Waisman, A. Gaur, P. Colon, N. Ling, P.J. Fairchild, D.C. Wraith, A. O'Garra, C.G. Fathman, and L. Steinman, Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein, Nature, 379: 343–346, 1996. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• A. Faith, C.A. Akdis, M. Akdis, A. Joss, D. Wymann, and K. Blaser, An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogatting TCR signalling, J. Immunol., 162: 1836–1842, 1999. [CSA]
   PubMedGoogle Scholar
• A.M. Woltman, J.W. de Fijter, S.W. Kamerling, L.C. Paul, M.R. Daha, and C. van Kooten, The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells, Eur. J. Immunol., 30: 1807–1812, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. Mehling, S. Grabbe, M. Voskort, T. Schwarz, T.A. Luger, and S. Beissert, Mycophenolate mofetil impairs the maturation and function of murine dendritic cells, J. Immunol., 165: 2374–2381, 2000. [CSA]
   PubMed Web of Science ®Google Scholar
• K. Steinbrink, M. Wolfl, H. Jonuleit, J. Knop, and A.H. Enk, Induction of tolerance by IL-10-treated dendritic cells, J. Immunol., 159: 4772–4780, 2000. [CSA]
   Google Scholar
• C. Rastellini, L. Lu, C. Ricordi, T.E. Starzl, A.S. Rao, and A.W. Thomson, Granulocyte–macrophage colony-stimulating factor-stimulated hepatic dendritic-cell progenitors prolong pancreatic islet allograft survival, Transplantation, 60: 1366–1370, 1995. [CSA]
   PubMed Web of Science ®Google Scholar
• Y.M. Huang, J.S. Yang, L.Y. Xu, H. Link, and B.G. Xiao, Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats, Clin. Exp. Immunol., 122: 437–444, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M.C. Nussenzweig, and R.M. Steinman, Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8 + T cell tolerance. J. Exp. Med., 196: 1627–1638, 2002. [CSA]
   PubMed Web of Science ®Google Scholar
• M. Maki, K. Mustalahti, J. Kokkonen, P. Kulmala, M. Haapalahti, T. Karttunen, J. Ilonen, K. Laurila, I. Dahlbom, T. Hansson, P. Hopfl, and M. Knip, Prevalence of Celiac disease among children in Finland, N. Engl. J. Med., 348: 2517–2524, 2003. [CSA]
   PubMed Web of Science ®Google Scholar
• L. Hogberg, P. Laurin, K. Falth-Magnusson, C. Grant, E. Grodzinsky, G. Jansson, H. Ascher, L. Browaldh, J.A. Hammersjo, E. Lindberg, , et al., Oats to children with newly diagnosed coeliac disease: a randomised double blind study, Gut, 53: 649–654, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.T. Naluai, S. Nilsson, A.H. Gudjonsdottir, A.S. Louka, H. Ascher, J. Ek, B. Hallberg, L. Samuelsson, B. Kristiansson, T. Martinsson, , et al., Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11, Eur. J. Hum. Genet., 9: 938–944, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E.M. Nilsen, F.L. Jahnsen, K.E. Lundin, F.E. Johansen, O. Fausa, L.M. Sollid, J. Jahnsen, H. Scott, and P. Brandtzaeg, Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease, Gastroenterology, 115: 551–563, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A. Fasano, T. Not, W. Wang, S. Uzzau, I. Berti, A. Tommasini, and S.E. Goldblum, Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease, Lancet, 355: 1518–1519, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O. Molberg, S.N. McAdam, R. Korner, H. Quarsten, C. Kristiansen, L. Madsen, L. Fugger, H. Scott, O. Noren, P. Roepstorff, , et al., Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease, Nat. Med., 4: 713–717, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. van de Wal, Y. Kooy, P. van Veelen, S. Pena, L. Mearin, G. Papadopoulos, and F. Koning, Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T-cell reactivity, J. Immunol., 161: 1585–1588, 1998. [CSA]
   PubMed Web of Science ®Google Scholar
• F. Hausch, L. Shan, N.A. Santiago, G.M. Gray, and C. Khosla, Intestinal digestive resistance of immunodominant gliadin peptides, Am. J. Physiol. Gastrointest. Liver Physiol., 283: G996–G1003, 2002. [CSA]
   PubMed Web of Science ®Google Scholar
• L. Shan, O. Molberg, I. Parrot, F. Hausch, F. Filiz, G.M. Gray, L.M. Sollid, and C. Khosla, Structural basis for gluten intolerance in celiac sprue. 2002, Science, 297: 2275–2279, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W. Vader, Y. Kooy, P. Van Veelen, A. De Ru, D. Harris, W. Benckhuijsen, S. Pena, L. Mearin, J.W. Drijfhout, and F. Koning, The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides, Gastroenterology, 122: 1729–1737, 2002. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Y. van der Wal, Y.M. Kooy, P.A. van Veelen, S.A. Pena, L.M. Mearin, O. Molberg, K.E. Lundin, L.M. Sollid, T. Mutis, W.E. Benckhuijsen, , et al., Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin, Proc. Natl. Acad. Sci. U. S. A., 95: 10050–10054, 1998. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• S. Sulkanen, T. Halttunen, K. Laurila, K.L. Kolho, I.R. Korponay-Szabo, A. Sarnesto, E. Savilahti, P. Collin, and M. Maki, Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease, Gastroenterology, 115: 1322–1328, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.M. Sollid, Molecular basis of celiac disease, Annu. Rev. Immunol., 18: 53–81, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Bajaj-Elliott, R. Poulsom, S.L. Pender, N.C. Wathen, and T.T. MacDonald, Interactions between stromal cell–derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia, J. Clin. Invest., 102: 1473–1480, 1998. [CSA]
   PubMedGoogle Scholar
• S. Daum, U. Bauer, H.D. Foss, D. Schuppan, H. Stein, E.O. Riecken, and R. Ullrich, Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease, Gut, 44: 17–25, 1999. [CSA]
   PubMed Web of Science ®Google Scholar
• B. Jabri, N.P. de Serre, C. Cellier, K. Evans, C. Gache, C. Carvalho, J.F. Mougenot, M. Allez, R. Jian, P. Desreumaux, , et al., Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease, Gastroenterology, 118: 867–879, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C. Gianfrani, R. Troncone, P. Mugione, E. Cosentini, M. De Pascale, C. Faruolo, S. Senger, G. Terrazzano, S. Southwood, S. Auricchio, and A. Sette, Celiac disease association with CD8+ T-cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope, J. Immunol., 170: 2719–2726, 2003. [CSA]
   PubMed Web of Science ®Google Scholar
• O. Molberg, K. Kett, H. Scott, E. Thorsby, L.M. Sollid, and K.E. Lundin, Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls, Scand. J. Immunol., 46: 103–109, 1997. [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• H. Sjostrom, K.E. Lundin, O. Molberg, R. Corner, S.N. McAdam, D. Anthonsen, H. Quarsten, O. Noren, P. Roepstorff, E. Thorsby, and L.M. Sollid, Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition, Scand. J. Immunol., 48: 111–115, 1998. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G. de Ritis, S. Auricchio, H.W. Jones, E.J. Lew, J.E. Bernardin, and D.D. Kasarda, In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease, Gastroenterology, 94: 41–49, 1988. [CSA]
   PubMed Web of Science ®Google Scholar
• L. Maiuri, R. Troncone, M. Mayer, S. Coletta, A. Picarelli, M. De Vincenzi, V. Pavone, and S. Auricchio, In vitro activities of A-gliadin-related synthetic peptides, Scand. J. Gastroenterol., 31: 247–253, 1996. [CSA]
   PubMed Web of Science ®Google Scholar
• F. Maurano, R.A. Siciliano, B. De Giulio, D. Luongo, M.F. Mazzeo, R. Troncone, S. Auricchio, and M. Rossi, Intranasal administration of one alpha gliadin can downregulate the immune response to whole gliadin in mice, Scand. J. Immunol., 53: 290–295, 2001. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Wieser, A. Mödl, W. Seilmeier, H.-D. Belitz, High-perfomance liquid chromatography of gliadins from different wheat varieties: amino acid composition and N-terminal amino acid sequence of components, Z. Lebens. Unters. Forsch., 185: 371–378, 1987. [CSA], [CROSSREF]
   Google Scholar
• M.F. Kagnoff, R.K. Austin, H.C.L. Johnson, J.E. Bernardin, M.D. Dietler, and D.D. Kasarda, Celiac sprue: correlation with murine T-cell responses to wheat gliadin components, J. Immunol., 129: 2693–2697, 1982. [CSA]
   PubMed Web of Science ®Google Scholar
• D.D. Kasarda, T.W. Okita, J.E. Bernardin, P.A. Baecker, C.C. Nimmo, E.J. Lew, M.D. Dietler, and F.C. Greene, Nucleic acid (cDNA) and amino acid sequences of alpha-type gliadins from wheat (Triticum aestivum) Proc. Natl. Acad. Sci. U. S. A., 81: 4712–4716, 1984. [CSA]
   PubMed Web of Science ®Google Scholar
• R.P. Anderson, P. Degano, A.J. Godkin, D.P. Jewell, and A.V. Hill, In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope, Nat. Med., 6: 337–342, 2000. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H.J. Ellis, E.L. Pollock, W. Engel, J.S. Fraser, S. Rosen-Bronson, H. Wieser, and P.J. Ciclitira, Investigation of the putative immunodominant T-cell epitopes in coeliac disease, Gut, 52: 212–217, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• T. Marti, O. Molberg, Q. Li, G.M. Gray, C. Khosla, and L.M. Sollid, Prolyl endopeptidase-mediated destruction of T-cell epitopes in whole gluten: chemical and immunological characterization, J. Pharmacol. Exp. Ther., 312: 19–26, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V.M. Salvati, G. Mazzarella, C. Gianfrani, M.K. Levings, R. Stefanile, B. De Giulio, G. Iaquinto, N. Giardullo, S. Auricchio, M.G. Roncarolo, , et al., Recombinant human interleukin 10 suppresses gliadin dependent T-cell activation in ex vivo cultured coeliac intestinal mucosa, Gut, 54: 46–53, 2005. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.A. Lowrey, N.D.L. Savage, D. Palliser, M. Corsin Jimenez, L.M.G. Forsyth, G. Hall, S. Lindey, G.A. Stewart, K.A.L. Tan, G.F. Hoyne, , et al., Induction of tolerance via the respiratory mucosa, Int. Arch. Allergy Immunol., 116: 93–102, 1998. [CSA], [CROSSREF]
   PubMedGoogle Scholar
• J. Tian, M.A. Atkinson, M. Clare Salzler, A. Herschenfeld, T. Forsthuber, P.V. Lehmann, and D.L. Kaufman, Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes, J. Exp. Med., 183: 1561–1567, 1996. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• H. Kiyono and S. Fukuyama, NALT- versus Peyer's-patch-mediated mucosal immunity, Nat. Rev. Immunol., 4: 699–710, 2004. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M. Rossi, F. Maurano, D. Luongo, S. Senger, R.A. Siciliano, B. Marotti, M.F. Mazzeo, S. Auricchio, and R. Troncone, Immunotherapy with gliadin peptides in mice. Proceedings of 10th International Symposium on Coeliac Disease. Montrouge: John Libbey Eurotext, pp. 259–267, 2003.
   Google Scholar
• D.A. Wolvers, C.J. Coenen-de Roo, R.E. Mebius, M.J. van der Cammen, F. Tirion, A.M. Miltenburg, and G. Kraal, Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39, J. Immunol., 162: 1994–1998, 1999. [CSA]
   PubMed Web of Science ®Google Scholar
• T.C. VanCott, R.W. Kaminski, J.R. Mascola, V.S. Kalyanaraman, N.M. Wassef, C.R. Alving, J.T. Ulrich, G.H. Lowell, and D.L. Birx, HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160, J. Immunol., 160: 2000–2012, 1998. [CSA]
   PubMed Web of Science ®Google Scholar
• R. Troncone and A. Ferguson, Gliadin presented via the gut induces oral tolerance in mice, Clin. Exp. Immunol., 72: 284–287, 1988. [CSA]
   PubMedGoogle Scholar
• M. Rossi, F. Maurano, N. Caputo, S. Auricchio, A. Sette, R. Capparelli, R. Troncone, Intravenous or intranasal administration of gliadin is able to down-regulate the specific immune response in mice, Scand. J. Immunol., 50: 177–182, 1999. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D.D. Kasarda and R. D'Ovidio, Deduced amino acid sequence of an α-gliadin gene from spelt wheat (Spelta) includes sequences active in celiac disease, Cereal. Chem., 76: 548–551, 1999. [CSA]
   Web of Science ®Google Scholar
• S. Senger, D. Luongo, F. Maurano, M.F. Mazzeo, R.A. Siciliano, C. Gianfrani, C. David, R. Troncone, S. Auricchio, and M. Rossi, Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice, Immunol. Lett., 88: 127–134, 2003. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar